Pharma and Biotech
| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | n/a | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | n/a | n/a |
| Pr/Book | 5.7 |
| Latest | F'cast | |
|---|---|---|
| Revenue | n/a | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | n/a | (5.25) | (19.29)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | n/a | (5.61) | (20.64)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | n/a | (5.10) | (0.18)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | n/a | n/a | (0.09)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-25 | n/a | (1.57) | (5.34)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Tirzzit Mapping Identifies New Mineralisation | 23-Jul-2026 | 07:00 | RNS |
| Publication of 2025 Annual Report | 29-Jun-2026 | 07:00 | RNS |
| Tirzzit Project Significant Channel Sample Results | 29-May-2026 | 07:00 | RNS |
| Schedule One - Ovoca Bio Plc | 31-Dec-2025 | ShareCast |
| Publication of Admission Document | 31-Dec-2025 | ShareCast |
| Notice of AGM | 31-Dec-2025 | ShareCast |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 6.25p |
| Change Today | 0.25p |
| % Change | 4.17 % |
| 52 Week High | 6.38p |
| 52 Week Low | 6.00p |
| Volume | 89,888 |
| Shares Issued | 64.17m |
| Market Cap | £4.01m |
| Value |
|
|---|
| Value |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 15:07 | 16,561 @ 6.34p |
| 14:59 | 710 @ 6.00p |
| 11:43 | 10,000 @ 6.35p |
| 10:48 | 50,000 @ 6.38p |
| 10:30 | 12,617 @ 6.01p |
| CEO | Timothy McCutcheon |
| CFO | Leah Ellen O’Donovan |
You are here: research